Medical News

3-month post-RT PSA levels May Predict Outcomes in Intermediate and High Risk Prostate Cancer

Outcomes such as biochemical progression-free survival (bPFS), prostate cancer-specific survival (PCSS), and overall survival (OS) in patients with...

23 Jul, 2018

 
Email this page
Intravesical BCG, A Novel Effective Treatment for High Grade pT1 Bladder Cancer

A recent Italian study demonstrated the efficacy of intravesical Bacille Calmette-Guerin (BCG) therapy in the treatment for high-grade (HG) pT1...

12 Jul, 2018

 
Email this page
Better Survival Rates with Early Salvage Androgen Deprivation Therapy in Prostate Cancer after Radical Prostatectomy

A recent propensity matched analysis concluded that disease progression-free survival (DPFS) and distant metastasis-free survival (DMFS) rates were...

05 Jul, 2018

 
Email this page
Night Work and Prostate Cancer Risk: Are these Linked?

EPICAP, a French population-based case-control study demonstrated no correlation between night work, either permanent or rotating, and prostate...

28 Jun, 2018

 
Email this page

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Bleomycin at a Glance

This publication provides information on indication, dosage, administration and adverse events of bleomycin.

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

Exemestane Plus Ovarian Suppression Demonstrates Sustained Higher Rates of Disease Free Survival in Premenopausal Women with Breast Cancer

This combined analysis of SOFT and TEXT trials showed that after a median follow-up of more than 8 years addition of ovarian suppression to...

LATITUDE Study: Abiraterone Plus Prednisone Might Be Clinically Beneficial in Men with Metastatic Castration-Sensitive Prostate Cancer

Combination of Abiraterone with ADT is highly efficacious in treating men with metastatic castration-sensitive prostate cancer with manageable...

ElderTac Study: Erlotinib, A Potential Palliative Treatment for Elderly Patients with Advanced NSCLC

This study assessed the effectiveness and tolerability of erlotinib in elderly patients with non-small-cell lung cancer (NSCLC) after ≥1 platinum-...

CREATE-X Trial: Adjuvant Capecitabine Safe and Effective in HER2-Negative Breast Cancer Patients

In CREATE -X trial, adjuvant capecitabine therapy demonstrated prolonged disease-free survival and overall survival in breast cancer patients.  

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer...

Myths and Facts about Cancer

Throughout the years there have been many cancer myths floating around. This article will help clear the myths related to cancer.

Infographics

Explore >>

Currently there is no content under this category.

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
50% (3 votes)
Tegafur uracil
0% (0 votes)
5-FU
50% (3 votes)
Total votes: 6